You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Flu vaccine response and HIV

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)

Not yet recruiting
  • Vaccine Response
  • Atlanta, Georgia
    Hope Clinic
Aug 29, 2023

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

Completed
  • HIV Infections
  • +2 more
    • Baltimore, Maryland
    • +1 more
    Mar 17, 2023

    Respiratory Syncytial Virus Infections Trial in New Zealand, Panama, South Africa (RSVPreF3 OA investigational vaccine, FLU-QIV)

    Completed
    Has Results
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA investigational vaccine
    • FLU-QIV
    • Auckland, New Zealand
    • +13 more
    Sep 20, 2022

    Herpes Zoster Trial in Tomball (HZ/su, Flu D-QIV, mRNA-1273)

    Active, not recruiting
    • Herpes Zoster
    • HZ/su
    • +2 more
    • Tomball, Texas
      GSK Investigational Site
    Apr 8, 2022

    Influenza, Human Trial (Flu mRNA, Control 1, Control 2)

    Not yet recruiting
    • Influenza, Human
    • Flu mRNA
    • +2 more
    • (no location specified)
    Apr 21, 2023

    Childhood Adversity, Inflammatory Reactivity and Persistent Pain

    Completed
    • Chronic Pain
    • +3 more
    • Tetravalent Influenza Vaccine
    • High-frequency electrical stimulation
    • Cape Town, Western Cape, South Africa
      University of Cape Town
    Nov 6, 2023

    RZV Vaccine (Shingrix ®) Trial in France, Switzerland (Recombinant Zoster Vaccine)

    Not yet recruiting
    • RZV Vaccine (Shingrix ®)
    • Recombinant Zoster Vaccine
    • Bordeaux, France
    • +7 more
    Oct 27, 2022

    Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA investigational vaccine
    • FLU vaccine
    • Edegem, Belgium
    • +33 more
    Dec 7, 2022

    Rheumatologic Disorder, IBD, Immune Complex Diseases Trial in East Setauket (Influenza vaccine)

    Completed
    • Rheumatologic Disorder
    • +2 more
    • Influenza vaccine
    • East Setauket, New York
      Clinical Research Center
    Feb 23, 2022

    HIV, Systemic Lupus Erythematosus Trial in Durham (AIDSVAX® B/E)

    Completed
    Has Results
    • HIV Infections
    • Systemic Lupus Erythematosus
    • AIDSVAX® B/E
    • Durham, North Carolina
      Duke Human Vaccine Institute CRS
    Jan 31, 2022

    HPV Infection, HPV Vaccination Trial in Thika (Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine)

    Recruiting
    • HPV Infection
    • HPV Vaccination
    • Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine
    • Thika, Kiambu, Kenya
      Phrd-Ccr-Kemri
    Jun 22, 2022

    Respiratory Syncytial Virus Infections Trial in United States (RSVPreF3 OA investigational vaccine, FLU HD vaccine)

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA investigational vaccine
    • FLU HD vaccine
    • Birmingham, Alabama
    • +46 more
    Jan 12, 2023

    HIV Trial in Boston, Seattle (HIV-1 DNA plasmid vaccine, HIV-1 recombinant Ad5 vaccine)

    Completed
    • HIV Infections
    • HIV-1 DNA plasmid vaccine
    • HIV-1 recombinant Ad5 vaccine
    • Boston, Massachusetts
    • +1 more
    Oct 13, 2021

    Immune Defect Trial in Miami (Fluzone Quadrivalent)

    Recruiting
    • Immune Defect
    • Fluzone Quadrivalent
    • Miami, Florida
      University of Miami
    Oct 17, 2022

    HIV Trial in Kericho (Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®)

    Active, not recruiting
    • HIV Infections
    • Env-C Plasmid DNA
    • +6 more
    • Kericho, Kenya
      Kenya Medical Research Institute/Walter Reed Project, Clinical R
    Feb 25, 2022

    HIV Trial in Kampala (VRC-HIVDNA009-00-VP, Placebo vaccine)

    Completed
    • HIV Infections
    • VRC-HIVDNA009-00-VP
    • Placebo vaccine
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    HIV Trial in Birmingham, Nashville, Seattle (Sub C gp140 Vaccine, MF59C.1 Adjuvant)

    Completed
    • HIV Infections
    • Sub C gp140 Vaccine
    • MF59C.1 Adjuvant
    • Birmingham, Alabama
    • +2 more
    Oct 13, 2021

    HIV Trial in Kampala (VRC-HIVADV014-00-VP Vaccine)

    Completed
    • HIV Infections
    • VRC-HIVADV014-00-VP Vaccine
    • Kampala, Uganda
      Makerere University Walter Reed Project (MUWRP)
    Oct 28, 2021

    HIV Trial in United States (VSV-Indiana HIV gag vaccine, Placebo injection (normal saline))

    Completed
    • HIV Infections
    • VSV-Indiana HIV gag vaccine
    • Placebo injection (normal saline)
    • San Francisco, California
    • +3 more
    Oct 13, 2021

    HIV Trial (DNA-HIV-PT123 vaccine, NYVAC-HIV-PT1 vaccine, NYVAC-HIV-PT4 vaccine)

    Withdrawn
    • HIV Infections
    • DNA-HIV-PT123 vaccine
    • +4 more
    • (no location specified)
    Oct 13, 2021

    HIV Trial in United States (MRKAd5 HIV-1 gag/pol/nef)

    Completed
    • HIV Infections
    • MRKAd5 HIV-1 gag/pol/nef
    • Birmingham, Alabama
    • +3 more
    Oct 13, 2021

    HIV Trial in Worldwide (PENNVAX-G DNA Vaccine, MVA-CMDR Vaccine, Placebo PENNVAX-G Vaccine)

    Completed
    • HIV Infections
    • PENNVAX-G DNA Vaccine
    • +3 more
    • Rockville, Maryland
    • +3 more
    Oct 28, 2021

    Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)

    Active, not recruiting
    • Influenza, Human
    • GSK4382276A Dose level 1
    • +4 more
    • Edegem, Belgium
    • +6 more
    Jan 9, 2023

    HIV Trial in United States (Clade B gag DNA/PLG and env DNA/PLG Microparticles, Clade B Recombinant, Oligomeric gp140/MF59

    Completed
    • HIV Infections
    • Clade B gag DNA/PLG and env DNA/PLG Microparticles
    • Clade B Recombinant, Oligomeric gp140/MF59 Adjuvant
    • Saint Louis, Missouri
    • +3 more
    Oct 13, 2021

    HIV Trial (DNA Nat-B env vaccine, NYVAC Nat-B env vaccine, DNA CON-S env vaccine)

    Withdrawn
    • HIV Infections
    • DNA Nat-B env vaccine
    • +7 more
    • (no location specified)
    Oct 13, 2021